Search results

  1. J

    Looking for Long Covid: A Clash of Definition and Study Design

    This is a deeply reported article. One criticism is that the author didn’t do enough to equate the “core” LC symptoms to MECFS. Hardly mentioned at all until the very end. I agree that Al Aly’s definition of LC is far too broad.
  2. J

    Looking for Long Covid: A Clash of Definition and Study Design

    Influential studies from the VA St. Louis take a broad view of long Covid. Not every expert agrees with the approach. https://undark.org/2024/07/25/long-covid-clash-of-definition-study-design/
  3. J

    Long Covid: Where Things Stand: Washington post live show, July 25th 2024, 9AM USA East Coast time

    Clip posted here https://www.s4me.info/threads/usa-the-recover-initiative-long-covid-research.30525/page-9#post-544911
  4. J

    Long Covid: Where Things Stand: Washington post live show, July 25th 2024, 9AM USA East Coast time

    It ended {no it didn’t} didn’t miss much—covered the basics—Jaime did pretty well in my opinion. Actually it’s still going on now—my bad. Only Jaime Seltzer segment ended
  5. J

    Long Covid: Where Things Stand: Washington post live show, July 25th 2024, 9AM USA East Coast time

    Well I tried to register but it told me I was too late—bah humbug. You can still watch it live here. https://www.washingtonpost.com/washington-post-live/2024/07/25/looming-public-health-challenge-long-covid/ I think you needed to register only if you wanted to ask questions.
  6. J

    Long Covid: Where Things Stand: Washington post live show, July 25th 2024, 9AM USA East Coast time

    With Jaime Seltzer, Aly Register here https://www.washingtonpost.com/washington-post-live/2024/07/25/looming-public-health-challenge-long-covid/
  7. J

    Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in [ME/CFS], 2024, Rekeland, Fluge, Mella et al.

    Possibly/probably Daratumumab. https://en.wikipedia.org/wiki/Daratumumab But I agree with you that it is much more helpful to specifically call out specific treatments by name, even if there is some speculation involved.
  8. J

    A Disease That Makes Children Age Rapidly Gets Closer to a Cure

    https://www.nytimes.com/2024/07/24/health/progeria-dna-base-editing.html?unlocked_article_code=1.9k0.q4xC.Uw4NrJXPahro&smid=url-share A disease that affects a couple dozen people worldwide gets closer to a cure……if only Francis would have had his lab investigate a disease that affects more people….
  9. J

    Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in [ME/CFS], 2024, Rekeland, Fluge, Mella et al.

    The baseline IGG data by responder data for cyclophosphamide which was included in the Rekeland dissertation was not included here. Also the HLA risk alleles data are not discussed at all here.
  10. J

    National Autistic Society says media reports on an autism cure study are ‘deeply insulting’

    https://www.learningdisabilitytoday.co.uk/news/national-autistic-society-says-autism-cure-study-is-deeply-insulting/ The National Autistic Society has slammed a ‘deeply insulting’ new study that was published in the national media this week claiming that autism can be ‘reversed’.
  11. J

    Protocol REVERSE-Long COVID-19 With Baricitinib Study (REVERSE-LC)

    From Chat GPT video summarizer (not sure how this works, but it works!) ### Summary of "Prof. E. Wesley Ely: Immunomodulation in Long Covid (Day 1, Block 4)" - **Introduction and Speaker Background**: - Dr. Wes Ely, a leading internist, pulmonologist, and critical care physician at...
  12. J

    Protocol REVERSE-Long COVID-19 With Baricitinib Study (REVERSE-LC)

    Immunomodulation in Long Covid Haven’t watched yet.
  13. J

    Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. (Widjaja, Cook, et al 2024)

    This is the drug. To achieve this goal, we administered a neutralizing IL-11 antibody (X203) or IgG control to aged mice and studied healthspan indices29,38(Fig. 3a). Anyone know what X203 is?
  14. J

    Protocol REVERSE-Long COVID-19 With Baricitinib Study (REVERSE-LC)

    If anyone has specific comments on this trial design/protocol, you can post here, and I can forward to Jaime—I don’t think this train has left the station yet.
  15. J

    CAR-T therapy

    CAR-Ts sweep into autoimmunity https://www.nature.com/articles/s41587-024-02321-0
  16. J

    [...] LC-MS/MS analysis of ME/CFS plasma reveals dysregulated coagulation [...], endothelial dysfunction, [...], 2024, Nunes, Kell, Pretorius et al

    Pretorius on editorial board… that’s why they are submitting there… doesn’t inspire confidence actually. Editorial Board Victor Aboyans, MD, PhD, FAHA, FESC, Department of Cardiology, Dupuytren Hospital and Limoges University, Limoges, France Professor Yehuda Adler, MD, MPH, Faculty of...
  17. J

    Protocol REVERSE-Long COVID-19 With Baricitinib Study (REVERSE-LC)

    From email from Jaime Seltzer: “I'm helping with that trial! Outside of my involvement, though, there is nothing to say that if you took the money from that trial it would automatically go towards something similar or better. This is one of many grants that received funding, and if Ely's...
Back
Top Bottom